Intercellular adhesion molecule-1 (ICAM-1) deficiency protects mice against severe forms of experimentally induced colitis
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
10606964
PubMed Central
PMC1905542
DOI
10.1046/j.1365-2249.2000.01090.x
PII: cei1090
Knihovny.cz E-zdroje
- MeSH
- autoprotilátky krev MeSH
- imunoglobulin A krev MeSH
- kolitida etiologie patologie prevence a kontrola MeSH
- mezibuněčná adhezivní molekula-1 genetika fyziologie MeSH
- modely nemocí na zvířatech MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- myši MeSH
- síran dextranu aplikace a dávkování toxicita MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- autoprotilátky MeSH
- imunoglobulin A MeSH
- mezibuněčná adhezivní molekula-1 MeSH
- síran dextranu MeSH
ICAM-1 (CD54), the ligand for LFA-1 and Mac-1, is up-regulated during inflammatory reaction on the activated vascular endothelium. To determine its role in intestinal inflammation, we induced acute experimental colitis in mice with a deleted ICAM-1 gene, by feeding them with 3% dextran sodium sulphate (DSS) in drinking water for 7 days. Chronic colitis was elicited by DSS similarly, followed by 2 weeks with water. In the acute phase of inflammation, ICAM-1-deficient mice exhibited a significantly lower mortality rate (5%) than control C57Bl/6J mice (35%). Control animals, but not the ICAM-1-deficient mice, exhibited diarrhoea and rectal bleeding. Histological examination of large-bowel samples evaluated the intensity of inflammatory changes, and type and extent of mucosal lesions. In the acute phase, 33.3% of samples from ICAM-1-deficient mice exhibited mucosal defects (flat and fissural ulcers), predominantly mild to moderate inflammatory infiltrate within the lamina propria mucosae and lower grades of mucosal lesions. Much stronger inflammatory changes were present in control animals, flat ulcers (sometimes multiple) and fissural ulcers being observed in 62.5% of samples. Mucosal inflammatory infiltrate was moderate to severe, typically with higher grades of mucosal lesions. In chronic colitis, smaller inflammatory changes were found in the large bowel. The two mouse strains differed, the chronic colitis being accompanied by an increased serum level of anti-epithelial IgA autoantibodies in C57Bl/6 control mice but not in ICAM-1-deficient mice. These findings provide direct evidence of the participation of ICAM-1 molecule in the development of experimentally induced intestinal inflammation.
Zobrazit více v PubMed
Burgio VL, Fais S, Boirivant M, Perrone A, Pallone F. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology. 1995;109:1029–38. PubMed
Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the mutistep paradigm. Cell. 1994;76:301–14. PubMed
Noronha-Blob L, Lowe VC, Mulhauser RO, Burch RM. NPC 15669, an inhibitor of neutrophil recruitment is efficacious in acetic acid-induced colitis in rats. Gastroenterology. 1993;104:1021–9. PubMed
Jones SC, Banks RE, Haidar A, et al. Adhesion molecules in inflammatory bowel disease. Gut. 1995;36:724–30. PubMed PMC
Pober JS, Gimbrone MA, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor and immune interferon. J Immunol. 1986;137:1893–6. PubMed
Yao Z, Painter SL, Fanslow WC, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol. 1995;155:5483–6. PubMed
Simmons D, Makgoba MW, Seed B. ICAM-1, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature. 1988;331:624–7. PubMed
Dustin ML, Rothlein R, Bahn AD, Dinarello CA, Springer TA. Induction by IL-1 and interferon: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1) J Immunol. 1986;137:245–54. PubMed
Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Ann Rev Immunol. 1993;11:767–804. PubMed
Ballantyne CM, O'brien WE, Beaudet AL. Nucleotide sequence of the cDNA for murine intercellular adhesion molecule-1 (ICAM-1) Nucl Acids Res. 1989;17:5853. PubMed PMC
Horley KJ, Carpenito C, Baker B, Takei F. Molecular cloning of murine intercellular adhesion molecule (ICAM-1) EMBO J. 1989;10:2889–96. PubMed PMC
Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule-1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J Immunol. 1991;147:2777. PubMed
Ballantyne CM, Sligh JE, Dai XY, Beaudet AL. Characterization of the murine ICAM-1 gene. Genomics. 1992;14:1076–80. PubMed
Sligh JE, Ballantyne CM, Rich SS, et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule-1. Proc Natl Acad Sci USA. 1993;90:8529–33. PubMed PMC
Xu H, Gonzalo JA, Pierre Y, et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med. 1994;180:95–109. PubMed PMC
Kelly KJ, Williams WW, Jr, Colvin RB, et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemical renal injury. J Clin Invest. 1996;97:1056–63. PubMed PMC
Soriano SG, Lipton SA, Wang YF, et al. Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann Neurol. 1996;39:618–24. PubMed
Bullard DC, King PD, Hicks MJ, Dupont B, Beaudet AL, Elkon KB. Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-FasIpr mice from early lethality. J Immunol. 1997;159:2058–67. PubMed
Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702. PubMed
Cooper HS, Murthy SNS, Shah RS, Sedegran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238–49. PubMed
Kolínská J, Kraml J, Zákostelecká M, Kadlecová L. Actinomycin D suppressed hydrocortisone-induced changes in distribution and sialylation of brush-border enzymes in jejunal villi and crypts. Biochem Int. 1990;21:581–91. PubMed
Tučková L, Tlaskalová-Hogenová H, Farré MA, et al. Molecular mimicry as a possible cause of autoimmune reactions in celiac disease? Antibodies to gliadin cross-react with epitopes on enterocytes. Clin Immunol Immunopathol. 1995;74:170–6. PubMed
Elson CO, Sartor RB, Tennyson GS, Ridell RH. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344–67. PubMed
Wong PY, Yue G, Yink Miyasaka M, et al. Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease. J Pharmacol Exp Ther. 1995;274:475–80. PubMed
Bennett CF, Kornbrust D, Henry S, et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther. 1997;280:988–1000. PubMed
Breider MA, Eppinger M, Gough A. Intercellular adhesion molecule-1 expression in dextran sulphate induced colitis in rats. Vet Pathol. 1997;34:598–604. PubMed
Bendjelloul F, Rossmann P, Malý P, Mandys V, Jirkovská M, Prokešová L, Tučková L, Tlaskalová-Hogenová H. The detection of ICAM-1 in experimentally induced colitis of ICAM-1 deficient and wild-type mice: an immunohistochemical study. Submitted PubMed
Bernstein CN, Sargent M, Gallatin WM. Beta2 integrin/ICAM expression in Crohn's disease. Clin Immunol Immunopathol. 1998;86:147–60. PubMed
Nielsen OH, Langholz E, Hendel J, Brynskov J. Circulating soluble intercellular adhesion molecule-1 (sICAM-1) in active inflammatory bowel disease. Dig Dis Sci. 1996;39:1918–23. PubMed
Parkos CA, Colgan SP, Diamond MS, et al. Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interaction with neutrophils. Mol Med. 1996;2:489–505. PubMed PMC
Panes J, Granger DN. Leucocyte–endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology. 1998;114:1066–90. PubMed
Yang H. Analysis of ICAM-1 gene polymorphism in immunologic subsets of inflammatory bowel disease. Exp Clin Immunogenet. 1997;14:214–25. PubMed
Shanahan F. The role of autoantibodies and autoimmunity in chronic inflammatory disorders of the gut. Curr Opin Gastroenterol. 1992;8:988–92.
Das KM, Squillante L, Robertson FM. Amplified expression of intercellular adhesion molecule-1 (ICAM-1) and M(r) 40K protein by DLD-1 colon tumor cells by interferon-gamma. Cell Immunol. 1993;147:215–21. PubMed
Strober W, Ehrhardt RO. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell. 1993;78:283–95. PubMed
Cebra JJ, Jiang H, Šterzl J, Tlaskalova-Hogenová H. The role of mucosal microbiota in the development and maintenance of the mucosal immune system. In: Ogra P, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, editors. Mucosal immunology. New York: Academic Press; 1999. pp. 267–80.
Andus T, Goebell H, Layer P, Scholmerich J. Dordrecht: Kluwer Ac. Publications; 1997. Inflammatory bowel diseases—from bench to bedside.
Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity. 1995;3:171–4. PubMed